24/7 suggests eight biotech trading near $5 with big upside potential

|By:, SA News Editor

24/7's Lee Jackson pinpoints eight small-cap biotech ideas, whose stocks all trade near $5 but with big upside potential; each company has promising clinical trials and in some cases FDA-approved products already on the market or soon to arrive.

Galena Biopharma (GALE) "may be the home run that biotech investors are looking for," and the stock may be an acquisition target; Novavax (NVAX) has six vaccine candidates undergoing clinical trials and a seventh being readied for a Phase I study later this year.

Jackson's other favorite biotech opportunities: ARRY, BIOD, PLX, RIGL, SNTA, ZGNX.

J.P. Morgan has three different ideas for aggressive risk-tolerant investors: ITMN, NPSP and PLX.